Heart Disease News and Research

Latest Heart Disease News and Research

5 things you should know about stem cell research

In just a few weeks, Michigan voters will have an important decision to make when casting their ballots.

13 Oct 2008

Obese teenagers face higher metabolic syndrome risk in South America than Europe

Obese teenagers are much more likely to suffer from metabolic syndrome - which can lead to heart disease - if they live in Brazil than Italy, according to a study in the October issue of IJCP, the International Journal of Clinical Practice.

13 Oct 2008

Link found between bisphenol A and heart disease

British scientists have revealed a possible link between the chemical bisphenol A (BPA) and disease in adults.

13 Oct 2008

Link found between mitochondria and tumor formation in stem cells

Researchers report on a previously unknown relationship between stem cell potency and the metabolic rate of their mitochondria -a cell's energy makers. Stem cells with more active mitochondria also have a greater capacity to differentiate and are more likely to form tumors.

12 Oct 2008

Vulnerable plaque may be easier to detect through optical coherence tomography

Research results indicate that optical coherence tomography (OCT), a newly evolving imaging method, may be the best tool available to detect vulnerable plaque in coronary arteries. The findings will be presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).

12 Oct 2008

Bisphenol A linked to diabetes and heart disease in adults

A research team from the Peninsula Medical School, the University of Exeter, the University of Plymouth and the University of Iowa, have found evidence linking Bisphenol A (BPA) to diabetes and heart disease in adults.

12 Oct 2008

New devices used to reduce arterial occlusions, provide cardiac support

Research results highlighting three new devices used to reduce blockages in peripheral and coronary arteries and to provide cardiac support will be presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).

12 Oct 2008

Study reveals that signs of heart disease are attributed to stress more frequently in women than men

Research presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF), found that coronary heart disease (CHD) symptoms presented in the context of a stressful life event were identified as psychogenic in origin when presented by women and organic in origin when presented by men. The study could help explain why there is often a delay in the assessment of women with heart disease.

12 Oct 2008

Body's built-in weapon against HIV explained

Humans have a built-in weapon against HIV, but until recently no one knew how to unlock its potential.

12 Oct 2008

Olmesartan may reduce coronary artery plaque

Research presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF), suggests that olmesartan, a drug commonly used to treat high blood pressure, may play a role in reducing coronary plaque

12 Oct 2008

Concerns raised over safety of 'electronic cigarettes'

The increasing popularity of 'electronic cigarettes' is causing concern in Britain.

12 Oct 2008

Testicles may be a source of stem cells

A team of researchers from Britain and Germany have found that a man's testicles may be a source of stem cells.

12 Oct 2008

Painkillers found to reduce breast cancer risk

According to an international study the regular use of popular painkillers such as aspirin and ibuprofen reduces the risk of breast cancer.

12 Oct 2008

Cheap 'Polypill' deals with heart disease and stroke

The 'Polypill' is a single pill which combines a range of drugs that protect against heart disease and stroke and was first considered a number of years ago as a cost effective way to significantly reduce the death toll from cardiovascular disease. But progress has been hampered by the reluctance of pharmaceutical companies to embark on a project involving inexpensive drugs which offered little financial incentive.

7 Oct 2008